Dublin, Aug. 10, 2016 -- Research and Markets has announced the addition of the "Traumatic Spinal Cord Injury Forecast in 15 Major Markets 2016-2026" report to their offering.
Spinal cord injury is defined as damage to any part of the spinal cord or nerves at the end of the spinal canal, often resulting in permanent changes in strength, sensation and other body functions below the site of the injury. Traumatic spinal cord injury (TSCI) is classified as injury to the spine caused by a traumatic event.
This report provides the current prevalent population for TSCI across 15 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan, India, Turkey, Canada, Netherlands, Australia, South Africa and China) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains an overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.
Providing a value-added level of insight from the analysis team, several of the main symptoms and co-morbidities of TSCI have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.
Main symptoms and co-morbidities for TSCI include:
- Deep Vein Thromboses (DVT)
- Urinary Tract Infections (UTI)
- Pressure sores
- Neuropathic pain
- Spasticity
Reason to buy:
- Able to quantify patient populations in global TSCI's market to target the development of future products, pricing strategies and launch plans.
- Gain further insight into the prevalence of the subdivided types of TSCI and identify patient segments with high potential.
- Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
- Provide a level of understanding on the impact from specific co-morbid conditions on TSCI's prevalent population.
- Identify sub-populations within TSCI which require treatment.
- Gain an understanding of the specific markets that have the largest number of TSCI patients.
Key Topics Covered:
1 List of Tables and Figures
2 Introduction
3 Cause of the Disease
4 Risk Factors & Prevention
5 Diagnosis of the Disease
6 Variation by Geography/Ethnicity
7 Disease Prognosis & Clinical Course
8 Key Co-morbid Conditions/Features Associated with the Disease
9 Methodology for Quantification of Patient Numbers
10 Top-Line Prevalence for Traumatic Spinal Cord Injury
- TSCI by Cause
- Location of TSCI
- Level of Impairment of TSCI
- Sequelae of TSCI
11 Abbreviations used in the Report
12 Patient-Based Offering
13 Online Pricing Data and Platforms
14 References
15 Appendix
For more information visit http://www.researchandmarkets.com/research/sqzcsv/traumatic_spinal
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals


Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb
TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave
Ford Issues Major Recall on Over 422,000 Vehicles Due to Windshield Wiper Defect
SpaceX IPO: Retail Investors to Play Historic Role in Record-Breaking Public Offering
Bill Ackman Eyes New Fund to Bet Against Market Complacency
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push
Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy
Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs
China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs
Anthropic Fights Pentagon Blacklisting in Dual Federal Court Battles 



